| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $240K | — | +87.5% |
| R&D Expense | $7.5M | +3125.9% | +464.4% |
| SG&A Expense | $2.8M | +4793.1% | +12.5% |
| Operating Income | -$10.1M | — | -163.8% |
| Interest Expense | $160K | — | -1.2% |
| Pre-tax Income | -$9.8M | — | -6.4% |
| Income Tax | $10K | — | -16.7% |
| Net Income | -$9.8M | -3284.8% | -9.0% |
| EPS (Basic) | -$0.19 | — | +48.6% |
| EPS (Diluted) | -$0.19 | — | +48.6% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $45.5M | -13.7% | +458.1% |
| Accounts Receivable | $413K | -34.1% | +105.5% |
| Inventory | $272K | -3.2% | — |
| Current Assets | $48.3M | -14.8% | -31.4% |
| Total Assets | $105.4M | -7.7% | +20.0% |
| Current Liabilities | $12.1M | +4.1% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.8M | — | -123.7% |
| Capital Expenditures | $6K | — | +0.0% |
| Investing Cash Flow | -$430K | — | -105.0% |
| Financing Cash Flow | -$30K | — | +37.5% |
| Free Cash Flow | -$6.8M | — | -123.5% |
| +66.8% |
| Total Liabilities | $16.2M | +2.9% | +55.0% |
| Stockholders' Equity | $85.2M | -9.8% | +15.9% |